Castlight Health Inc (NYSE:CSLT) has been assigned an average recommendation of “Hold” from the six analysts that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating and four have issued a hold rating on the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $1.38.
CSLT has been the topic of a number of recent research reports. Wells Fargo & Co decreased their price target on shares of Castlight Health from $1.15 to $0.75 and set an “underweight” rating on the stock in a research note on Tuesday, May 19th. Zacks Investment Research downgraded shares of Castlight Health from a “buy” rating to a “hold” rating in a research note on Monday, June 22nd. Finally, Canaccord Genuity reiterated a “hold” rating on shares of Castlight Health in a research note on Thursday, May 14th.
CSLT stock traded up $0.02 on Thursday, reaching $0.83. 7,403 shares of the company were exchanged, compared to its average volume of 1,248,169. Castlight Health has a 12 month low of $0.60 and a 12 month high of $3.20. The stock’s fifty day moving average price is $0.79 and its 200 day moving average price is $0.96. The firm has a market capitalization of $121.77 million, a PE ratio of -1.40 and a beta of 1.51. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.84 and a quick ratio of 1.84.
Castlight Health (NYSE:CSLT) last posted its quarterly earnings results on Thursday, May 7th. The software maker reported ($0.01) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.07) by $0.06. Castlight Health had a negative net margin of 58.42% and a negative return on equity of 18.61%. The firm had revenue of $39.05 million for the quarter, compared to the consensus estimate of $32.80 million. As a group, research analysts expect that Castlight Health will post -0.23 EPS for the current fiscal year.
Several large investors have recently modified their holdings of CSLT. Metropolitan Life Insurance Co NY acquired a new stake in shares of Castlight Health in the 1st quarter valued at $97,000. California Public Employees Retirement System lifted its position in Castlight Health by 54.2% during the 4th quarter. California Public Employees Retirement System now owns 106,400 shares of the software maker’s stock worth $142,000 after buying an additional 37,405 shares in the last quarter. State Street Corp lifted its position in Castlight Health by 1.8% during the 4th quarter. State Street Corp now owns 1,830,678 shares of the software maker’s stock worth $2,435,000 after buying an additional 31,869 shares in the last quarter. Tower Research Capital LLC TRC lifted its position in Castlight Health by 35.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 35,558 shares of the software maker’s stock worth $47,000 after buying an additional 9,293 shares in the last quarter. Finally, FMR LLC lifted its position in Castlight Health by 0.7% during the 4th quarter. FMR LLC now owns 16,652,219 shares of the software maker’s stock worth $22,147,000 after buying an additional 121,058 shares in the last quarter. Institutional investors own 53.35% of the company’s stock.
About Castlight Health
Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers implementation, user and customer support, and marketplace services.
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.